Literature DB >> 8872894

Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis.

B F Bebo1, T Yong, E L Orr, D S Linthicum.   

Abstract

Mast cells and their potent chemical mediators are known to initiate and modulate a number of important inflammatory cascades. With respect to the central nervous system, the role of mast cells as participants in the promotion and resolution of inflammation has been widely underestimated. Mast cell-derived histamine, serotonin, kallikreins, and tumor necrosis factor-alpha (TNF-alpha) can enhance microvascular permeability, leukocyte rolling, adhesion, and extravasation of inflammatory cells into the brain and spinal cord. Mast cell mediators may play an important role in autoimmune encephalomyelitis and multiple sclerosis by promoting the entry of autoreactive T cells and the recruitment of nonspecific monocytes across the blood:brain barrier.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872894     DOI: 10.1002/(SICI)1097-4547(19960815)45:4<340::AID-JNR3>3.0.CO;2-9

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  22 in total

1.  Mast cells in the sheep, hedgehog and rat forebrain.

Authors:  H C Michaloudi; G C Papadopoulos
Journal:  J Anat       Date:  1999-11       Impact factor: 2.610

2.  Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system.

Authors:  Roxana del Rio; Rajkumar Noubade; Naresha Saligrama; Emma H Wall; Dimitry N Krementsov; Matthew E Poynter; James F Zachary; Robin L Thurmond; Cory Teuscher
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

3.  Mast cells in the rat brain synthesize gonadotropin-releasing hormone.

Authors:  Mona H Khalil; Ann-Judith Silverman; Rae Silver
Journal:  J Neurobiol       Date:  2003-08

Review 4.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

Authors:  Margaret E Walker; Julianne K Hatfield; Melissa A Brown
Journal:  Biochim Biophys Acta       Date:  2011-02-25

5.  The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo.

Authors:  J Reckless; L M Tatalick; D J Grainger
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

6.  Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE.

Authors:  H H Hofstetter; R Mössner; K P Lesch; R A Linker; K V Toyka; R Gold
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

7.  Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia.

Authors:  James G Alb; Jorge D Cortese; Scott E Phillips; Roger L Albin; Tim R Nagy; Bruce A Hamilton; Vytas A Bankaitis
Journal:  J Biol Chem       Date:  2003-06-04       Impact factor: 5.157

8.  Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.

Authors:  Naresha Saligrama; Laure K Case; Roxana del Rio; Rajkumar Noubade; Cory Teuscher
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

9.  Neuropeptides activate human mast cell degranulation and chemokine production.

Authors:  Marianna Kulka; Cecilia H Sheen; Brian P Tancowny; Leslie C Grammer; Robert P Schleimer
Journal:  Immunology       Date:  2007-10-06       Impact factor: 7.397

10.  Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice.

Authors:  Rajkumar Noubade; Graeme Milligan; James F Zachary; Elizabeth P Blankenhorn; Roxana del Rio; Mercedes Rincon; Cory Teuscher
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.